| Name | tert-butyl 4-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate |
|---|---|
| Synonyms |
RW2824
1-Piperidinecarboxylic acid, 4-hydroxy-4-(hydroxymethyl)-, 1,1-dimethylethyl ester t-butyl 4-hydroxy-4-(hydroxymethyl)tetrahydropyridine-1 (2H)-carboxylate 2-Methyl-2-propanyl 4-hydroxy-4-(hydroxymethyl)-1-piperidinecarboxylate 4-hydroxy-4-hydroxymethyl-piperidine-1-carboxylic acid tert-butyl ester 1-Boc-4-hydroxy-4-(hydroxymethyl)-piperidine |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 350.9±27.0 °C at 760 mmHg |
| Molecular Formula | C11H21NO4 |
| Molecular Weight | 231.289 |
| Flash Point | 166.0±23.7 °C |
| Exact Mass | 231.147064 |
| PSA | 70.00000 |
| LogP | 0.00 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.507 |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933399090 |
|
~%
389889-80-9 |
| Literature: Ogino, Yoshio; Kurihara, Hideki; Matsuda, Kenji; Numazawa, Tomoshige; Otake, Norikazu; Noguchi, Kazuhito Patent: US2003/191316 A1, 2003 ; Location in patent: Page/Page column 36 ; |
|
~%
389889-80-9 |
| Literature: NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; Location in patent: Page/Page column 197 ; |
|
~%
389889-80-9 |
| Literature: NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
|
~%
389889-80-9 |
| Literature: NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
|
~%
389889-80-9 |
| Literature: NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
|
~%
389889-80-9 |
| Literature: NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
| Precursor 7 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |